{"entity":{"type":"insider","cik":"0001291962","url":"/insider/0001291962","json_url":"/insider/0001291962.json","name":"Hacksell Uli","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":23,"first":"2004-06-04","last":"2019-04-01","span_basis":"filed_date"},"name_variants":[{"name":"Hacksell Uli","source":"filing","n_filings":23,"first_seen":"2004-06-04","last_seen":"2019-04-01"}],"transactions":[{"id":8192624,"accession":"0001578563-19-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-19-000008","line_url":"/filing/0001578563-19-000008#line-2","is_derivative":false,"issuer_cik":"0001291962","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001291962","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.42,"price_display":"0.42","price_state":"stated","total_value":4200.0,"total_display":"4,200.00","total_whole":"4,200","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-09","filed_date":"2019-04-01","scope":"insider"},{"id":8192620,"accession":"0001578563-19-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-19-000008","line_url":"/filing/0001578563-19-000008#line-1","is_derivative":false,"issuer_cik":"0001291962","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001291962","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.07,"price_display":"1.07","price_state":"stated","total_value":10700.0,"total_display":"10,700.00","total_whole":"10,700","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-10","filed_date":"2019-04-01","scope":"insider"},{"id":8154557,"accession":"0001415889-15-000614","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-15-000614","line_url":"/filing/0001415889-15-000614#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":34.2956,"price_display":"34.30","price_state":"stated","total_value":1028868.0,"total_display":"1,028,868.00","total_whole":"1,028,868","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-19","scope":"insider"},{"id":8636725,"accession":"0001415889-15-000169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-15-000169","line_url":"/filing/0001415889-15-000169#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":33.981,"price_display":"33.98","price_state":"stated","total_value":1019430.0,"total_display":"1,019,430.00","total_whole":"1,019,430","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-14","filed_date":"2015-01-16","scope":"insider"},{"id":7039273,"accession":"0001415889-14-003915","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-003915","line_url":"/filing/0001415889-14-003915#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.9972,"price_display":"31.00","price_state":"stated","total_value":929916.0,"total_display":"929,916.00","total_whole":"929,916","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-17","scope":"insider"},{"id":6507370,"accession":"0001415889-14-003735","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-003735","line_url":"/filing/0001415889-14-003735#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":29.2799,"price_display":"29.28","price_state":"stated","total_value":878397.0,"total_display":"878,397.00","total_whole":"878,397","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-26","scope":"insider"},{"id":6193716,"accession":"0001415889-14-003050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-003050","line_url":"/filing/0001415889-14-003050#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":24.151,"price_display":"24.15","price_state":"stated","total_value":724530.0,"total_display":"724,530.00","total_whole":"724,530","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-10","scope":"insider"},{"id":6944547,"accession":"0001415889-14-002797","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-002797","line_url":"/filing/0001415889-14-002797#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":27.3607,"price_display":"27.36","price_state":"stated","total_value":820821.0,"total_display":"820,821.00","total_whole":"820,821","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-10","filed_date":"2014-09-12","scope":"insider"},{"id":6242582,"accession":"0001415889-14-002539","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-002539","line_url":"/filing/0001415889-14-002539#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":22.8914,"price_display":"22.89","price_state":"stated","total_value":343371.0,"total_display":"343,371.00","total_whole":"343,371","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-15","scope":"insider"},{"id":6242564,"accession":"0001415889-14-002158","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-002158","line_url":"/filing/0001415889-14-002158#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.2187,"price_display":"22.22","price_state":"stated","total_value":444374.0,"total_display":"444,374.00","total_whole":"444,374","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-14","filed_date":"2014-07-16","scope":"insider"},{"id":6838858,"accession":"0001415889-14-001886","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-001886","line_url":"/filing/0001415889-14-001886#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.1002,"price_display":"23.10","price_state":"stated","total_value":462004.0,"total_display":"462,004.00","total_whole":"462,004","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-16","filed_date":"2014-06-18","scope":"insider"},{"id":7089029,"accession":"0001415889-14-001212","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-001212","line_url":"/filing/0001415889-14-001212#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.7534,"price_display":"17.75","price_state":"stated","total_value":443835.0,"total_display":"443,835.00","total_whole":"443,835","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-17","scope":"insider"},{"id":7020251,"accession":"0001415889-14-000662","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-000662","line_url":"/filing/0001415889-14-000662#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.1411,"price_display":"24.14","price_state":"stated","total_value":603527.5,"total_display":"603,527.50","total_whole":"603,528","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":6712605,"accession":"0001415889-14-000167","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-000167","line_url":"/filing/0001415889-14-000167#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.0115,"price_display":"24.01","price_state":"stated","total_value":600287.5,"total_display":"600,287.50","total_whole":"600,288","shares_owned_after":115549.0,"shares_owned_after_display":"115,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":5546821,"accession":"0001415889-13-002513","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-002513","line_url":"/filing/0001415889-13-002513#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.4538,"price_display":"23.45","price_state":"stated","total_value":351807.0,"total_display":"351,807.00","total_whole":"351,807","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4799805,"accession":"0001415889-13-002169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-002169","line_url":"/filing/0001415889-13-002169#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.2425,"price_display":"23.24","price_state":"stated","total_value":348637.5,"total_display":"348,637.50","total_whole":"348,638","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-01","scope":"insider"},{"id":4833068,"accession":"0001415889-13-001644","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-13-001644","line_url":"/filing/0001415889-13-001644#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52771.0,"shares_display":"52,771","price_per_share":20.1448,"price_display":"20.14","price_state":"stated","total_value":1063061.2408,"total_display":"1,063,061.24","total_whole":"1,063,061","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-13","filed_date":"2013-08-15","scope":"insider"},{"id":5556232,"accession":"0001415889-13-000873","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-13-000873","line_url":"/filing/0001415889-13-000873#line-8","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20449.0,"shares_display":"20,449","price_per_share":12.3427,"price_display":"12.34","price_state":"stated","total_value":252395.8723,"total_display":"252,395.87","total_whole":"252,396","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-02","filed_date":"2013-05-03","scope":"insider"},{"id":5556228,"accession":"0001415889-13-000873","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-000873","line_url":"/filing/0001415889-13-000873#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19551.0,"shares_display":"19,551","price_per_share":12.7113,"price_display":"12.71","price_state":"stated","total_value":248518.6263,"total_display":"248,518.63","total_whole":"248,519","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-01","filed_date":"2013-05-03","scope":"insider"},{"id":5215910,"accession":"0001415889-13-000777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-000777","line_url":"/filing/0001415889-13-000777#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16729.0,"shares_display":"16,729","price_per_share":12.3168,"price_display":"12.32","price_state":"stated","total_value":206047.7472,"total_display":"206,047.75","total_whole":"206,048","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":4555276,"accession":"0001415889-13-000634","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-000634","line_url":"/filing/0001415889-13-000634#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":7.6761,"price_display":"7.68","price_state":"stated","total_value":307044.0,"total_display":"307,044.00","total_whole":"307,044","shares_owned_after":109049.0,"shares_owned_after_display":"109,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-03","scope":"insider"},{"id":7076341,"accession":"0001181431-07-074151","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-07-074151","line_url":"/filing/0001181431-07-074151","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":12.5365,"price_display":"12.54","price_state":"stated","total_value":175511.0,"total_display":"175,511.00","total_whole":"175,511","shares_owned_after":59916.0,"shares_owned_after_display":"59,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider","n_lines":8},{"id":7111188,"accession":"0001181431-07-055716","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001181431-07-055716","line_url":"/filing/0001181431-07-055716","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":14.921797142857143,"price_display":"14.92","price_state":"stated","total_value":208905.16,"total_display":"208,905.16","total_whole":"208,905","shares_owned_after":78916.0,"shares_owned_after_display":"78,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-09-04","filed_date":"2007-09-04","scope":"insider","n_lines":13},{"id":8202780,"accession":"0001181431-07-033816","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-07-033816","line_url":"/filing/0001181431-07-033816","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":12.892454571428571,"price_display":"12.89","price_state":"stated","total_value":451235.91,"total_display":"451,235.91","total_whole":"451,236","shares_owned_after":110015.0,"shares_owned_after_display":"110,015","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-16","filed_date":"2007-05-18","scope":"insider","n_lines":6},{"id":267442,"accession":"0001179044-04-000116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179044-04-000116","line_url":"/filing/0001179044-04-000116#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291962","owner_name":"Hacksell Uli","owner_display_name":"Hacksell Uli","owner_url":"/insider/0001291962","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2100.0,"total_display":"2,100.00","total_whole":"2,100","shares_owned_after":98216.0,"shares_owned_after_display":"98,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":46,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Cerecor Inc.","url":"/issuer/0001534120","role":"Director","n_filings":1,"first_seen":"2019-04-01","last_seen":"2019-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Director, Officer (CEO)","n_filings":22,"first_seen":"2004-06-04","last_seen":"2015-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291962","retrieved_at":"2026-08-24T01:08:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}